Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT00898079 : Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
AgesMin: N/A Max: 30 Years
Inclusion Criteria:

- Meets any of the following criteria:

- Diagnosed with primary neoplasm

- Developed a second malignant neoplasm

- Any diagnoses having an ICD-O Morphology Code ending in 1, 2, or 3 as listed in
the International Classification of Disease for Oncology, Third Edition

- Must have biological specimens including solid tumors and leukemias available

- Solid tumors meeting the following criteria:

- Snap frozen primary tumor OR OCT embedded primary tumor OR formalin fixed
(block or tissue in formalin) primary tumor AND at least 10 unstained
paraffin slides for NIH Mandated QC (tumors that have undergone central
pathology review are allowed)

- Slides for pathology review (instead of slides for QC) are required
for patients with rare tumors

- Pleural fluid or cytologic specimens meeting the following criteria:

- At least 1 mL of fluid and at least 2 unstained cytospin slides (or 2
unstained smears)

- Slides for pathology review (instead of slides for QC) are required
for patients with rare tumors


- 3-6 mL of bone marrow aspirate and 10 mL of whole blood

- Not eligible for disease-specific biology or banking protocol
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557